Actively Recruiting
Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients
Led by Novo Nordisk A/S · Updated on 2026-02-13
900
Participants Needed
7
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study has descriptive purposes, with aim of assessing how turoctocog alfa is used in the everyday practice and to provide a baseline for the management of haemophilia A and does not involve any change in the clinical management of participants. Data will be extrapolated from the existing paper based medical records and uploaded to an electronic database specifically created for the study. Baseline information/history will be recorded at time of switching from previous FVIII replacement therapy to turoctocog alfa from the enrolled participants and outcomes will be collected according to participants visit format.
CONDITIONS
Official Title
Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients, both children and adults
- Patients diagnosed with haemophilia A of any severity
- Patients treated on-demand or with prophylaxis
- Patients previously treated with factor VIII replacement therapy
You will not qualify if you...
- Patients with coagulation disorders other than haemophilia A, such as Von Willebrand disease
- Patients with documented presence of any factor VIII inhibitor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
National centre for Hamophilia
Baghdad, Iraq, 10001
Enrolling by Invitation
2
Novo Nordisk Investigational Site
Baghdad, Iraq
Actively Recruiting
3
Basrah Haemoplhilia centre
Basra, Iraq, 61001
Not Yet Recruiting
4
Hilla Haemophilia centre
Hillah, Iraq, 51001
Enrolling by Invitation
5
Karbala Haemophilia centre
Karbala, Iraq, 56001
Enrolling by Invitation
6
Kirkuk Centre for Cancer and Blood Disorders
Kirkuk, Iraq, 36001
Enrolling by Invitation
7
Najaf Haemophilia Centre
Najaf, Iraq, 54001
Enrolling by Invitation
Research Team
N
Novo Nordisk
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here